Viewing Study NCT00116935


Ignite Creation Date: 2025-12-24 @ 10:36 PM
Ignite Modification Date: 2026-03-22 @ 1:05 AM
Study NCT ID: NCT00116935
Status: COMPLETED
Last Update Posted: 2011-12-30
First Post: 2005-06-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study Comparing 12 Months Versus 36 Months of Imatinib in the Treatment of Gastrointestinal Stromal Tumor (GIST)
Sponsor: Scandinavian Sarcoma Group
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sarcoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Gastrointestinal stromal tumor View
None GIST View
None Sarcoma View
None Imatinib View
None Adjuvant therapy View
None KIT View
None PDGFRA View
None Receptor tyrosine kinase View
None Tyrosine kinase inhibitor View